During the past decade, Vanderbilt University Medical Center - IBD Clinic conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vanderbilt University Medical Center - IBD Clinic" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Gilead Sciences" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Shire" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vanderbilt University Medical Center - IBD Clinic" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Galapagos NV" with 2 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Vanderbilt University Medical Center - IBD Clinic" are "Ulcerative Colitis" (5 trials), "Crohn's Disease" (4 trials), "Crohn Disease" (1 trials), "Crohn's Enteritis" (1 trials) and "Fistulizing Crohn's Disease" (1 trials). Many other conditions were trialed in "Vanderbilt University Medical Center - IBD Clinic" in a lesser frequency.

Most popular intervention types in "Vanderbilt University Medical Center - IBD Clinic" are "Drug" (11 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Filgotinib" (5 trials), "Placebo to match filgotinib" (2 trials), "0 mg Induction ONLY" (1 trials) and "150 mg Induction/Chronic" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vanderbilt University Medical Center - IBD Clinic" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Vanderbilt University Medical Center - IBD Clinic". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Vanderbilt University Medical Center - IBD Clinic, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Vanderbilt University Medical Center - IBD Clinic, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".